Navigate Up
UPMC/University of Pittsburgh Schools of the Health Sciences
For Journalists
Manager
Telephone: 412-623-4701 or 412-586-9773
Director
Telephone: 412-586-9777
Other Inquiries

GIST Cancer Research Fund Supports UPCI Gastrointestinal Cancer Research for 7th Year in a Row

PITTSBURGH, Aug. 23, 2012 – For the seventh year in a row, researchers from the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter, have received funding from the GIST Cancer Research Fund – a patient-driven organization that funds research on gastrointestinal stromal tumors (GISTs). These tumors occur in the gastrointestinal tract and initially can be successfully treated with the targeted therapy drug Gleevec, but rapidly develop resistance to the treatment.
 
The $120,000 award supports the research of Anette Duensing, M.D., assistant professor of pathology, University of Pittsburgh School of Medicine. According to Dr. Duensing, GIST research in her laboratory aims to better understand the biology of GIST responses to Gleevec, as well as the mechanisms underlying drug resistance. These studies provide the framework for developing more effective treatment options for GIST patients.
 
This year’s award pushes the total amount of money Dr. Duensing has received from the GIST Cancer Research Fund to more than $720,000. “This generous funding makes up a substantial part of my laboratory’s budget and has allowed us to continue investigating why GIST patients develop resistance to Gleevec,” said Dr. Duensing.
 
Previously, Dr. Duensing identified a novel protein crucial for the tumor cell response to Gleevec. Manipulating levels of this protein in GIST cells results in a faster and more effective destruction of the tumor cells.
 
The GIST Cancer Research Fund was founded in 2001 by Tania Stutman, who was diagnosed with the disease in 1998. Since its founding, the fund has raised and awarded more than $4 million for GIST research. Dr. Duensing’s laboratory is one of only five institutes nationally that the fund supports.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com